November 4, 2021
Nature Nanotechnology
Istituto di Ricerche Farmacologiche Mario Negri (Italy)
Commentary article
Copyright © 2021, Springer Nature Limited
document
adverse events,COVID-19,lipid nanoparticles,mRNA,vaccine ingredients,vaccines
Commentary article
Copyright © 2021, Springer Nature Limited